ON

Ondine Biomedical Inc.

Develops photodisinfection-based therapies to prevent and treat infections.

OBI | TSXV

Overview

Corporate Details

ISIN(s):
CA68234M2058
LEI:
9845005B69E07CGF4A56
Country:
Canada
Address:
SUITE 888 - 1100 MELVILLE ST, V6E 4A6 VANCOUVER

Description

Ondine Biomedical Inc. is a life sciences company that develops and commercializes photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens. The company's patented platform technology involves applying a photosensitive agent to a targeted area, followed by illumination with non-thermal laser light. This process creates an oxidative burst that rapidly destroys pathogens like bacteria, viruses, and fungi without inducing microbial resistance. Its lead product, Steriwave™, is a nasal decolonization therapy used to eradicate pathogens in the nasal cavity, primarily to reduce the risk of healthcare-associated infections (HAIs) such as post-operative surgical site infections. The company's product pipeline is exploring applications for chronic rhinosinusitis, burns, wounds, and ventilator-associated pneumonia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-04 18:23
Notification of major holdings - M&G
English 24.6 KB
2025-09-04 18:20
Notification of major holdings - Robert Cross
English 53.5 KB
2025-09-04 18:17
Notification of major holdings - Carolyn Cross
English 53.3 KB
2025-09-03 08:00
Ondine to present Health Economic Data at ICPIC
English 14.7 KB
2025-09-01 08:00
Total Voting Rights Correction
English 14.0 KB
2025-08-28 08:00
Result of Fundraise & TVR
English 60.3 KB
2025-08-27 17:52
Proposed c.£11m Fundraise
English 155.0 KB
2025-08-13 11:52
First Mexican Hospital Steriwave Deployment
English 14.8 KB
2025-08-11 08:00
Ex-President of Mexico Champions APDT to Cut AMR
English 15.5 KB
2025-07-22 18:38
Share Issuance for ICU Study Enrollment Completion
English 16.8 KB
2025-07-21 10:00
UK Axes Financial support for AMR Fleming Fund
English 16.2 KB
2025-07-21 08:00
Steriwave ICU Study Completes Recruitment
English 19.5 KB
2025-07-14 08:00
Growing Use of Steriwave Across Surgery Types
English 20.2 KB
2025-07-08 11:21
Steriwave in Half of Fraser Health Hospitals
English 18.7 KB
2025-07-01 08:00
Ondine Appoints Peel Hunt as Broker
English 13.5 KB

Automate Your Workflow. Get a real-time feed of all Ondine Biomedical Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ondine Biomedical Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ondine Biomedical Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.